These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11882622)

  • 1. Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
    Zhuo JL; Mendelsohn FA; Ohishi M
    Hypertension; 2002 Feb; 39(2 Pt 2):634-8. PubMed ID: 11882622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
    Zhuo J; Casley D; Murone C; Mendelsohn FA
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story.
    Ferrari R; Fox K
    Drugs; 2009; 69(3):265-77. PubMed ID: 19275271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
    Ceconi C; Fox KM; Remme WJ; Simoons ML; Bertrand M; Parrinello G; Kluft C; Blann A; Cokkinos D; Ferrari R; ;
    Cardiovasc Res; 2007 Jan; 73(1):237-46. PubMed ID: 17140552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice.
    Akishita M; Shirakami G; Iwai M; Wu L; Aoki M; Zhang L; Toba K; Horiuchi M
    J Hypertens; 2001 Jun; 19(6):1083-8. PubMed ID: 11403357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.
    Morawietz H; Rohrbach S; Rueckschloss U; Schellenberger E; Hakim K; Zerkowski HR; Kojda G; Darmer D; Holtz J
    Eur J Clin Invest; 2006 Oct; 36(10):705-12. PubMed ID: 16968466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway.
    Silvestre JS; Bergaya S; Tamarat R; Duriez M; Boulanger CM; Levy BI
    Circ Res; 2001 Oct; 89(8):678-83. PubMed ID: 11597990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L; Yu DM
    Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits.
    Hickey H; Makdissi M; Hyland R; Wilks D; Dusting GJ
    J Mol Cell Cardiol; 1996 Sep; 28(9):1985-94. PubMed ID: 8899557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial nitric oxide synthase-independent effects of an ACE inhibitor on coronary flow response to bradykinin in aged mice.
    Talukder MA; Fujiki T; Morikawa K; Motoishi M; Matsuo Y; Hatanaka M; Tsutsui M; Takeshita A; Shimokawa H
    J Cardiovasc Pharmacol; 2004 Nov; 44(5):557-63. PubMed ID: 15505492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
    Kim S; Zhan Y; Izumi Y; Iwao H
    Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography.
    Sakaguchi K; Jackson B; Chai SY; Mendelsohn FA; Johnson CI
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):710-7. PubMed ID: 2467090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.